Graham Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,674	Closed	-$899K	–	1385
2022 Q4	$899K	Sell	23,674 -293,095	-93%	-$11.1M	0.03%	561
2022 Q3	$7.96M	Buy	316,769 +220,748	+230%	+$5.55M	0.32%	35
2022 Q2	$2.92M	Buy	96,021 +31,884	+50%	+$969K	0.12%	114
2022 Q1	$2.1M	Buy	+64,137	New	+$2.1M	0.07%	113